van Schaik Digna J F, Klijn Alexandra F J, van Hout Hein P J, van Marwijk Harm W J, Beekman Aartjan T F, de Haan Marten, van Dyck Richard
Department of General Practice, Institute of Extramural Medicine (EMGO), VU University Medical Centre, Amsterdam, The Netherlands.
Gen Hosp Psychiatry. 2004 May-Jun;26(3):184-9. doi: 10.1016/j.genhosppsych.2003.12.001.
Patients' preferences in the treatment of depression are important in clinical practice and in research. Antidepressant medication is often prescribed, but adherence is low. This may be caused by patients preferring psychotherapy, which is often not available in primary care. In randomized clinical trials, patients' preferences may affect the external validity. The aim of this article is to study patients' preferences regarding psychotherapy and antidepressant medication and the impact of these preferences on treatment outcome. A systematic review of the literature was performed. The majority of patients preferred psychotherapy in all available studies. Antidepressants were often regarded as addictive and psychotherapy was assumed to solve the cause of depression. Discussing and supporting preferences as part of a quality improvement program of depression care, resulted in more patients receiving the treatment that was most suitable to them. In two patient-preference trials, preferences did not influence treatment outcome. It can be concluded that a substantial percentage of well-informed patients prefer psychotherapy. Patients with strong preferences, mostly for psychotherapy, are likely not to enter antidepressant treatment or randomized clinical trials if their preferences are not supported.
患者在抑郁症治疗中的偏好对于临床实践和研究都很重要。抗抑郁药物经常被开出处方,但依从性很低。这可能是因为患者更喜欢心理治疗,而心理治疗在初级保健中往往无法获得。在随机临床试验中,患者的偏好可能会影响外部效度。本文的目的是研究患者对心理治疗和抗抑郁药物的偏好,以及这些偏好对治疗结果的影响。我们对文献进行了系统综述。在所有现有研究中,大多数患者更喜欢心理治疗。抗抑郁药常被视为成瘾性药物,而心理治疗被认为可以解决抑郁症的病因。将讨论和支持患者偏好作为抑郁症护理质量改进计划的一部分,使得更多患者接受了最适合他们的治疗。在两项患者偏好试验中,偏好并未影响治疗结果。可以得出结论,相当比例的知情患者更喜欢心理治疗。如果他们的偏好得不到支持,偏好强烈(大多是对心理治疗的偏好)的患者很可能不会接受抗抑郁治疗或参加随机临床试验。